I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 121 filers reported holding I MAB in Q1 2022. The put-call ratio across all filers is 1.75 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,305,059 | -1.7% | 988,681 | +122.6% | 0.00% | – |
| Q2 2023 | $1,328,128 | -65.6% | 444,190 | -60.2% | 0.00% | – |
| Q1 2023 | $3,858,494 | -42.0% | 1,115,172 | -29.9% | 0.00% | -100.0% |
| Q4 2022 | $6,651,514 | -12.4% | 1,591,271 | -15.9% | 0.00% | 0.0% |
| Q3 2022 | $7,589,000 | -71.7% | 1,892,804 | -20.3% | 0.00% | -66.7% |
| Q2 2022 | $26,847,000 | +1.8% | 2,375,968 | +46.3% | 0.00% | -25.0% |
| Q1 2022 | $26,381,000 | -61.8% | 1,624,408 | +11.4% | 0.00% | -55.6% |
| Q4 2021 | $69,112,000 | -33.5% | 1,458,356 | +1.7% | 0.01% | -35.7% |
| Q3 2021 | $103,937,000 | +162.3% | 1,433,812 | +203.7% | 0.01% | +180.0% |
| Q2 2021 | $39,629,000 | +253.5% | 472,047 | +104.1% | 0.01% | +150.0% |
| Q1 2021 | $11,212,000 | +25.7% | 231,306 | +22.2% | 0.00% | +100.0% |
| Q4 2020 | $8,923,000 | +17.3% | 189,236 | +17.0% | 0.00% | 0.0% |
| Q3 2020 | $7,607,000 | +45.1% | 161,753 | -7.6% | 0.00% | 0.0% |
| Q2 2020 | $5,242,000 | +130.4% | 175,129 | +0.1% | 0.00% | 0.0% |
| Q1 2020 | $2,275,000 | – | 175,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 222,136 | $768,591 | 0.86% |
| HHLR ADVISORS, LTD. | 6,954,442 | $24,062,369 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 310,499 | $1,074,327 | 0.30% |
| Maso Capital Partners Ltd | 100,000 | $346 | 0.23% |
| Artal Group S.A. | 850,000 | $2,941 | 0.18% |
| Virtus ETF Advisers LLC | 26,347 | $91,161 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 96,555 | $334 | 0.03% |
| CAXTON ASSOCIATES LP | 53,793 | $186,124 | 0.03% |
| Diametric Capital, LP | 13,924 | $48,177 | 0.02% |
| Tekla Capital Management LLC | 162,580 | $562,527 | 0.02% |